
Advanced Enzyme Technologies and Advance Agrolife reported strong standalone quarterly results for March 2026. Advanced Enzyme's net sales rose 33.49% to Rs 116.41 crore, with net profit doubling to Rs 22.30 crore and EBITDA increasing 71.23%. Advance Agrolife's net sales grew 37.9% to Rs 123.88 crore, net profit surged over 422% to Rs 7.46 crore, and EBITDA rose 150.57%. Both companies saw significant EPS growth and their shares closed higher on May 7, 2026.
The articles focus on financial performance data without political framing. Both companies' earnings and sales growth are presented factually, reflecting a business and economic perspective. There is no evident political viewpoint or ideological framing in the coverage, as the content centers on corporate financial disclosures.
The tone across the articles is positive, highlighting substantial year-on-year growth in sales, profits, and earnings per share for both companies. The coverage emphasizes financial gains and improved performance metrics, conveying an optimistic sentiment regarding the companies' recent quarters.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| moneycontrol | Advance Agro Standalone March 2026 Net Sales at Rs 123.88 crore, up 37.9 Y-o-Y- Moneycontrol.com | Center | Positive |
| moneycontrol | Advanced Enzyme Standalone March 2026 Net Sales at Rs 116.41 crore, up 33.49 Y-o-Y- Moneycontrol.com | Center | Positive |
moneycontrol broke this story on 11 May, 05:35 am. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.